Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
Completed clinical trial evaluating cardiac magnetic resonance T1 mapping for diagnosing cardiac amyloidosis.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: SGLT2 Inhibition in Hemodialysis [Phase 2]
Phase 2 trial evaluating SGLT2 inhibitors in patients undergoing hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: ReNEW Clinic Cohort Study
A completed-status update for the ReNEW Clinic Cohort Study sponsored by Johns Hopkins University, covering hypertension, prehypertension an…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Role of ARNi in Ventricular Remodeling in Hypertensive LVH [Phase 2]
A Phase 2 trial evaluating whether an angiotensin receptor-neprilysin inhibitor can influence ventricular remodeling in patients with hypert…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Impact of a Family History of Hypertension and Physical Activity on Left Ventricular Mass
The completed trial assessed how a family history of hypertension and physical activity influence left ventricular mass, with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure [Phase 2]
Phase 2 trial evaluating the efficacy of mirabegron for prevention of heart failure in the context of left ventricular hypertrophy; the stud…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy [NA]
This clinical trial update indicates the study evaluating a targeted notification and clinical support pathway for individuals with left ven…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
A completed noninterventional, single-center feasibility study evaluating measures of heart failure risk.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Mechanism of Decompensation Evaluation - Aortic Stenosis
A completed University of Edinburgh clinical trial evaluating the mechanism of decompensation in aortic stenosis, with investigation into my…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. [Phase 4]
A Phase 4 trial comparing sacubitril/valsartan with amlodipine in patients with hypertension and left ventricular hypertrophy.
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Empagliflozin and Cardiac Remodelling in People Without Diabetes [Phase 4]
Phase 4 trial assessing empagliflozin for cardiac remodeling in people without diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease [Phase 4]
Phase 4 clinical trial evaluating the effect of blood pressure control on improvement of left ventricular hypertrophy in hypertension patien…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) [Phase 3]
Phase 3 LIFE study update on losartan intervention for hypertension and left ventricular hypertrophy; completed trial.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention [Phase 2, Phase 3]
Phase 2/3 trial investigating the effect of dapagliflozin on myocardial and renal function after aortic valve intervention.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis [Phase 3]
Phase 3 clinical trial update evaluating ACE inhibitors in patients on hemodialysis for left ventricular hypertrophy and hypertension has co…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants [Phase 4]
Phase 4 trial evaluating the combination of Everolimus and Tacrolimus for regression of left ventricular hypertrophy in renal transplant pat…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients [Phase 4]
Phase 4 trial updating the effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? [Phase 4]
Phase 4 trial evaluating whether allopurinol reduces left ventricular hypertrophy in patients with treated hypertension.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? [Phase 4]
Phase 4 trial evaluating whether dapagliflozin can regress left ventricular hypertrophy in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease [Phase 4]
Phase 4 trial evaluating MetfoRmin and its effects on left ventricular hypertrophy in normotensive patients with coronary artery disease; st…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy [Phase 4]
Phase 4 trial investigating the effects of levosimendan in patients eligible for aortic valve replacement with left ventricular hypertrophy;…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH [Phase 4]
Phase 4 trial update assessing the efficacy and safety of Valsartan alone and in combination with Nebivolol for hypertensive patients with l…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) [NA]
A completed clinical trial (TEAM Amylose) investigated the frequency of cardiac amyloidosis in Caribbean patients with left ventricular hype…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy [Phase 4]
Phase 4 clinical trial reporting reduction of left ventricular hypertrophy with eplerenone therapy in patients with hypertension and obstruc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study
This clinical trial update reports long-term follow-up results for in-centre nocturnal hemodialysis (INHD) in patients with end-stage renal …